Born out of a promise. Today GPI debuts on MTA, already strong thanks to the experience gained on AIM Italia, as promised to its shareholders in 2016 at the time of the business combination with Capital For Progress 1: to grow, and to make the stock more and more interesting. Talking about it, with the pride of someone who has worked hard to achieve their goal, is Fausto Manzana, President and CEO of the leading company in information systems and services for Health and Social Welfare. GPI debuts on the MTA: what are the objectives? The transition from the AIM Italia list to the MTA represents the keeping of a promise made to our shareholders. Today, GPI has more than 650 investors, and to have the choice of a more liquid market is a response to the desire to make the share more and more interesting. It is time to focus increasingly on the growth and evolution of our company, consolidating its presence on the national market and expanding its activities in Europe. What do you bring with you with respect to the experience gained on AIM Italia? The two years on AIM Italia have been a very good training ground for our team and has prepared us for the new challenge that we have undertaken today. We started from a business organisation based on a single partner and a single administrator. AIM Italia encouraged internal growth, new organisation, the development of adequate skills in comparison with competitors aimed at enhancing competitiveness. What are the growth drivers for 2019? We will continue on the path that we have been following up to today, aiming at growth for both internal and external lines. In 2018 we made 9 acquisitions, it will be fundamental to continue working on harmonising these ten projects (including GPI), equipping them with a unique soul. At the same time, however, we are also aiming to grow through new targeted acquisitions, in Italy and in Europe, both to expand our customer base and to broaden the range of services offered. The expected growth for 2018 in 2017 exceeded 10%, a not insignificant figure. We would like to accelerate this, at the same time being aware of always having to pay great attention to the financial balance. On the other hand, if it is true that the IT world is moving forward at great speed, it is also true that it is moving to provide an even healthier environment. Growth is always a necessity for remaining competitive and up to date. GPI is growing abroad thanks to robotics and the management of blood transfusion centres. How important is the 'Made in Italy' brand? There is great appreciation of the Italian offer. Shortly before Christmas we received many orders from various countries around the world for services related to the management of internal pharmacies. We are working to strengthen our commercial network but the feedback from abroad, where we are present, is very positive. In the internal market, on the other hand, what goals have you set for yourself? We are present in all Italian regions. It is possible to imagine a strengthening of the presence of our services in the southern regions, where there is a delay in investments in IT. More generally, in the next 5 years about 50% of current clinicians will retire, so it would be impossible not to invest in IT services on this occasion. The role of these figures will also be destined to change and increase thanks to the support of IT tools able to free them from bureaucratic problems, therefore improving the offer for the patient. The future of health is digital. At what stage is Italy? Compared to the countries of Northern Europe and North America, Italy has always invested little in IT. Since the economic crisis, these investments have been further reduced, driven by the mistaken belief that they represent costs rather than opportunities. It's time to take them back and strengthen them. Clinical IT is an asset that should not be underestimated for the growth of the country. We must be aware of ourselves and our potential. Geographically Italy has the opportunity to act as a reference area for the Mediterranean basin. Why not seize the opportunities deriving from health tourism? The Italian offer, including the public, is among the best. We have the tools to grow.